earticle

영어

There are very big trend changes in the pharmaceutical business. In spite of huge information from "-omics" researches, there are rather reduced new drugs in development. And we can no more expect blockbuster drugs like a cholesterol drug "Lipito". Instead, people often raise issues of personalized medicines, stratified medicines, and pharmacogenetics. And another big issue is also raising, integration of therapy and diagnostics, namely theragnostics or companion diagnostics. In this presentation, background of these changes, important roll of diagnostics, trends in diagnostics market including several companies, value chains of diagnostics area, and to do area of diagnostics will be discussed.